NFKB1 and neoplasm: Beyond its effects via the PPARs pathway, EA also blocks tumor cell proliferation, apoptotic resistance, and the synthesis of pro-inflammatory mediators (e.g., IL-6, TNF-α) through inhibition of NF-κB signaling (67, 68).